Drug Detail

Information about GDC-0449 + RO4929097

Generic Name
IND	GDC-0449 + RO4929097
Brand Name (US)
Manufacturer
Drug Type
Delivery	Oral
Approval Status
Indications
Overall Strategy	Oncogenic Signal Path Based
Strategy	Block Hedgehog & Notch pathways
Drug Category	PTCH/SMO inhibitor + Gamma Secretase inhibitor

Links
Trials of this drug
	GDC-0449 and RO4929097 in Treating Patients With Advanced or Metastatic Sarcoma

Trial results